Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : YEEHAW CANDIDATES -- Ignore unavailable to you. Want to Upgrade?

To: Jibacoa who wrote (9262)	7/13/2005 4:37:42 PM
From: Galirayo	Read Replies (1) \| Respond to of 23958

Thank You ... Sir Bernard .. I think I'll Add Stops to it in the Folio. How do you like to Choose your Stops ?? An EMA or another way?

To: Jibacoa who wrote (9262)	7/14/2005 12:29:30 PM
From: Galirayo	Read Replies (1) \| Respond to of 23958

Bernard .. May I ask a question about VPHM ?? When these Notes are converted to Common are they able to be sold or are they Restricted? TIA, Ray bizjournals.com ViroPharma will convert debt into common stock Wednesday July 6, 10:31 am ET ViroPharma Inc. said Wednesday it plans to exercise its right to automatically convert the remaining $15.35 million principal amount of its convertible senior secured notes, due October 2009, into 6.14 million shares of common stock. ADVERTISEMENT The Exton, Pa., biopharmaceutical company issued $75 million of convertible senior notes in connection with its acquisition of Vancocin, a treatment of antibiotic-associated infection of the gut known as pseudomembranous colitis, from Eli Lilly & Co. The auto-conversion will occur on July 12. "With this final auto conversion, we will have eliminated the entirety of the 2009 convertible senior notes from our balance sheet," said Vincent Milano, the chief financial officer of ViroPharma (NASDAQ: VPHM - News). Milano said the company has reduced its overall debt by 57 percent during the past two months.